RxAll is a digital infrastructure platform for healthcare that aims to address the $1.25T problem of access to affordable and safe drugs. The company was founded in 2016 and operates in the Big Data, Enterprise, and Hardware industries. RxAll provides on-demand access to high-quality medicines at manufacturer/wholesale prices to hospitals, pharmacies, and patients through a curated network of wholesalers and pharmaceutical companies.
The company's tech stack includes RxScanner, a proprietary instant drug testing platform that allows sellers to authenticate the medicines they sell, and RxPOS, which helps manage and sell inventory in-store and online through the RxDelivered marketplace. Additionally, RxAll offers embedded fintech solutions with RxPay to finance invoices for buyers on the platform, ensuring the availability and affordability of high-quality medicines from pharma company and wholesaler partners to B2B2C customers.
The latest milestone for RxAll was its $3.15M Seed Round investment on 21st July 2021. The investment was made by LoftyInc Alpha Fund, SOSV, Uncovered Fund, Future Africa, KSK Angel Fund, Launch Africa, Angel Challenge, century oak capital, and Plug & Play Mexico. With a vision to enable universal access to high-quality medicines at the lowest prices, RxAll is focused on initiating this mission in Africa.
